USD 0.05
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2015 | 6.98 Million USD | -29.65% |
2014 | 9.93 Million USD | 0.0% |
2013 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | -100.0% |
2009 | 312.00 USD | -61.76% |
2008 | 816.00 USD | -94.39% |
2007 | 14.53 Thousand USD | 187.33% |
2006 | 5058.00 USD | 0.0% |
2005 | - USD | -100.0% |
2004 | 43.56 Thousand USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2016 Q1 | 2.28 Million USD | 343.13% |
2015 Q1 | 1.01 Million USD | -45.8% |
2015 Q3 | 711.36 Thousand USD | -84.99% |
2015 Q4 | 515.88 Thousand USD | -27.48% |
2015 FY | 6.98 Million USD | -29.65% |
2015 Q2 | 4.74 Million USD | 364.94% |
2014 FY | 9.93 Million USD | 0.0% |
2014 Q4 | 1.88 Million USD | 0.0% |
2013 FY | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 FY | - USD | -100.0% |
2010 Q2 | - USD | 0.0% |
2009 Q1 | 240.00 USD | 0.0% |
2009 Q4 | - USD | -100.0% |
2009 FY | 312.00 USD | -61.76% |
2009 Q3 | 48.00 USD | 100.0% |
2009 Q2 | 24.00 USD | -90.0% |
2008 FY | 816.00 USD | -94.39% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | -100.0% |
2007 Q2 | 5099.00 USD | -22.99% |
2007 Q1 | 6621.00 USD | 694.84% |
2007 Q3 | 2014.00 USD | -60.5% |
2007 Q4 | 799.00 USD | -60.33% |
2007 FY | 14.53 Thousand USD | 187.33% |
2006 Q4 | 833.00 USD | -1.3% |
2006 Q2 | - USD | -100.0% |
2006 Q1 | 2455.00 USD | 0.0% |
2006 Q3 | 844.00 USD | 0.0% |
2006 FY | 5058.00 USD | 0.0% |
2005 FY | - USD | -100.0% |
2005 Q3 | - USD | -100.0% |
2005 Q4 | - USD | 0.0% |
2005 Q2 | 926.00 USD | 0.0% |
2004 FY | 43.56 Thousand USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
American Medical Technologies Inc. | 3.19 Million USD | 100.0% |
Ansell Limited | 1.61 Billion USD | 100.0% |
Ansell Limited | 1.61 Billion USD | 100.0% |
BG Medicine, Inc. | - USD | NaN% |
Biotage AB (publ) | 184.64 Million USD | 100.0% |
BioLife Sciences Inc. | - USD | NaN% |
CB Scientific, Inc. | 135.05 Thousand USD | 100.0% |
Psykey, Inc. | 419.29 Thousand USD | 100.0% |
ConvaTec Group Plc | 2.19 Billion USD | 100.0% |
ConvaTec Group Plc | 2.14 Billion USD | 100.0% |
Encision Inc. | 6.58 Million USD | 100.0% |
Hear AtLast Holdings, Inc. | - USD | NaN% |
Innovative MedTech Inc. | 1.82 Million USD | 100.0% |
LifePoint, Inc. | -18.5 Thousand USD | 100.0% |
Medite Cancer Diagnostics, Inc. | 6.81 Million USD | 100.0% |
Paradigm Medical Industries, Inc. | 772 Thousand USD | 100.0% |
QuantRx Biomedical Corporation | - USD | NaN% |
Remedent, Inc. | 986.22 Thousand USD | 100.0% |
Reflect Scientific, Inc. | 1.08 Million USD | 100.0% |
SmileDirectClub, Inc. | 470.74 Million USD | 100.0% |
Sector 10, Inc. | - USD | NaN% |
Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 100.0% |
SheerVision, Inc. | 3.49 Million USD | 100.0% |
United Health Products, Inc. | - USD | NaN% |
Vasamed, Inc. | 1.38 Million USD | 100.0% |
Wearable Health Solutions, Inc. | 745.09 Thousand USD | 100.0% |
Yubo International Biotech Limited | 104.28 Thousand USD | 100.0% |